Literature DB >> 29243970

Reactive oxygen species damage drives cardiac and mitochondrial dysfunction following acute nano-titanium dioxide inhalation exposure.

Cody E Nichols1,2, Danielle L Shepherd1,3, Quincy A Hathaway1,3, Andrya J Durr1,3, Dharendra Thapa1, Alaeddin Abukabda4, Jinghai Yi4, Timothy R Nurkiewicz3,4, John M Hollander1,3.   

Abstract

Nanotechnology offers innovation in products from cosmetics to drug delivery, leading to increased engineered nanomaterial (ENM) exposure. Unfortunately, health impacts of ENM are not fully realized. Titanium dioxide (TiO2) is among the most widely produced ENM due to its use in numerous applications. Extrapulmonary effects following pulmonary exposure have been identified and may involve reactive oxygen species (ROS). The goal of this study was to determine the extent of ROS involvement on cardiac function and the mitochondrion following nano-TiO2 exposure. To address this question, we utilized a transgenic mouse model with overexpression of a novel mitochondrially-targeted antioxidant enzyme (phospholipid hydroperoxide glutathione peroxidase; mPHGPx) which provides protection against oxidative stress to lipid membranes. MPHGPx mice and littermate controls were exposed to nano-TiO2 aerosols (Evonik, P25) to provide a calculated pulmonary deposition of 11 µg/mouse. Twenty-four hours following exposure, we observed diastolic dysfunction as evidenced by E/A ratios greater than 2 and increased radial strain during diastole in wild-type mice (p < 0.05 for both), indicative of restrictive filling. Overexpression of mPHGPx mitigated the contractile deficits resulting from nano-TiO2 exposure. To investigate the cellular mechanisms associated with the observed cardiac dysfunction, we focused our attention on the mitochondrion. We observed a significant increase in ROS production (p < 0.05) and decreased mitochondrial respiratory function (p < 0.05) following nano-TiO2 exposure which were attenuated in mPHGPx transgenic mice. In summary, nano-TiO2 inhalation exposure is associated with cardiac diastolic dysfunction and mitochondrial functional alterations, which can be mitigated by the overexpression of mPHGPx, suggesting ROS contribution in the development of contractile and bioenergetic dysfunction.

Entities:  

Keywords:  Mitochondria; antioxidant; cardiac function; reactive oxygen species; titanium dioxide

Mesh:

Substances:

Year:  2017        PMID: 29243970      PMCID: PMC5777890          DOI: 10.1080/17435390.2017.1416202

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  59 in total

1.  Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart.

Authors:  Rajaganapathi Jagannathan; Dharendra Thapa; Cody E Nichols; Danielle L Shepherd; Janelle C Stricker; Tara L Croston; Walter A Baseler; Sara E Lewis; Ivan Martinez; John M Hollander
Journal:  Circ Cardiovasc Genet       Date:  2015-09-16

2.  Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.

Authors:  Walter A Baseler; Erinne R Dabkowski; Courtney L Williamson; Tara L Croston; Dharendra Thapa; Matthew J Powell; Trust T Razunguzwa; John M Hollander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

3.  The role of nodose ganglia in the regulation of cardiovascular function following pulmonary exposure to ultrafine titanium dioxide.

Authors:  Hong Kan; Zhongxin Wu; Yen-Chang Lin; Teh-Hsun Chen; Jared L Cumpston; Michael L Kashon; Steve Leonard; Albert E Munson; Vincent Castranova
Journal:  Nanotoxicology       Date:  2013-05-07       Impact factor: 5.913

4.  Whole-body nanoparticle aerosol inhalation exposures.

Authors:  Jinghai Yi; Bean T Chen; Diane Schwegler-Berry; Dave Frazer; Vince Castranova; Carroll McBride; Travis L Knuckles; Phoebe A Stapleton; Valerie C Minarchick; Timothy R Nurkiewicz
Journal:  J Vis Exp       Date:  2013-05-07       Impact factor: 1.355

5.  Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice.

Authors:  Michael Bauer; Susan Cheng; Mohit Jain; Soeun Ngoy; Catherine Theodoropoulos; Anna Trujillo; Fen-Chiung Lin; Ronglih Liao
Journal:  Circ Res       Date:  2011-03-03       Impact factor: 17.367

6.  Cardiac and mitochondrial dysfunction following acute pulmonary exposure to mountaintop removal mining particulate matter.

Authors:  Cody E Nichols; Danielle L Shepherd; Travis L Knuckles; Dharendra Thapa; Janelle C Stricker; Phoebe A Stapleton; Valerie C Minarchick; Aaron Erdely; Patti C Zeidler-Erdely; Stephen E Alway; Timothy R Nurkiewicz; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-23       Impact factor: 4.733

7.  Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging.

Authors:  Danielle L Shepherd; Cody E Nichols; Tara L Croston; Sarah L McLaughlin; Ashley B Petrone; Sara E Lewis; Dharendra Thapa; Dustin M Long; Gregory M Dick; John M Hollander
Journal:  J Mol Cell Cardiol       Date:  2015-12-03       Impact factor: 5.000

8.  Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling.

Authors:  Timothy R Nurkiewicz; Dale W Porter; Ann F Hubbs; Samuel Stone; Bean T Chen; David G Frazer; Matthew A Boegehold; Vincent Castranova
Journal:  Toxicol Sci       Date:  2009-03-06       Impact factor: 4.849

9.  The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products.

Authors:  K Schnurr; J Belkner; F Ursini; T Schewe; H Kühn
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

10.  Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes.

Authors:  Erinne R Dabkowski; Walter A Baseler; Courtney L Williamson; Matthew Powell; Trust T Razunguzwa; Jefferson C Frisbee; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-11       Impact factor: 4.733

View more
  16 in total

Review 1.  Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure.

Authors:  Ekaterina Mostovenko; Christopher G Canal; MiJin Cho; Kirti Sharma; Aaron Erdely; Matthew J Campen; Andrew K Ottens
Journal:  Pharmacol Ther       Date:  2022-01-24       Impact factor: 13.400

Review 2.  Cardiovascular adaptations to particle inhalation exposure: molecular mechanisms of the toxicology.

Authors:  Amina Kunovac; Quincy A Hathaway; Mark V Pinti; Andrew D Taylor; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-19       Impact factor: 4.733

3.  Enhanced antioxidant capacity prevents epitranscriptomic and cardiac alterations in adult offspring gestationally-exposed to ENM.

Authors:  Amina Kunovac; Quincy A Hathaway; Mark V Pinti; Andrya J Durr; Andrew D Taylor; William T Goldsmith; Krista L Garner; Timothy R Nurkiewicz; John M Hollander
Journal:  Nanotoxicology       Date:  2021-05-08       Impact factor: 5.913

4.  Composable Microfluidic Plates (cPlate): A Simple and Scalable Fluid Manipulation System for Multiplexed Enzyme-Linked Immunosorbent Assay (ELISA).

Authors:  Ziyi He; Justin Huffman; Kathrine Curtin; Krista L Garner; Elizabeth C Bowdridge; Xiaojun Li; Timothy R Nurkiewicz; Peng Li
Journal:  Anal Chem       Date:  2020-12-16       Impact factor: 6.986

5.  Maternal Nanomaterial Inhalation Exposure: Critical Gestational Period in the Uterine Microcirculation is Angiotensin II Dependent.

Authors:  Krista L Garner; Elizabeth C Bowdridge; Julie A Griffith; Evan DeVallance; Madison G Seman; Kevin J Engels; Caroline P Groth; William T Goldsmith; Kim Wix; Thomas P Batchelor; Timothy R Nurkiewicz
Journal:  Cardiovasc Toxicol       Date:  2022-01-23       Impact factor: 2.755

6.  Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure.

Authors:  Alaeddin Bashir Abukabda; Carroll Rolland McBride; Thomas Paul Batchelor; William Travis Goldsmith; Elizabeth Compton Bowdridge; Krista Lee Garner; Sherri Friend; Timothy Robert Nurkiewicz
Journal:  Part Fibre Toxicol       Date:  2018-11-09       Impact factor: 9.400

7.  ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure.

Authors:  Amina Kunovac; Quincy A Hathaway; Mark V Pinti; William T Goldsmith; Andrya J Durr; Garrett K Fink; Timothy R Nurkiewicz; John M Hollander
Journal:  Part Fibre Toxicol       Date:  2019-06-18       Impact factor: 9.400

8.  Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure.

Authors:  S B Fournier; S Kallontzi; L Fabris; C Love; P A Stapleton
Journal:  Cardiovasc Toxicol       Date:  2019-08       Impact factor: 3.231

9.  miRNA-378a as a key regulator of cardiovascular health following engineered nanomaterial inhalation exposure.

Authors:  Quincy A Hathaway; Andrya J Durr; Danielle L Shepherd; Mark V Pinti; Ashley N Brandebura; Cody E Nichols; Amina Kunovac; William T Goldsmith; Sherri A Friend; Alaeddin B Abukabda; Garrett K Fink; Timothy R Nurkiewicz; John M Hollander
Journal:  Nanotoxicology       Date:  2019-02-01       Impact factor: 5.913

10.  Common Gene Expression Patterns in Environmental Model Organisms Exposed to Engineered Nanomaterials: A Meta-Analysis.

Authors:  Michael Burkard; Alexander Betz; Kristin Schirmer; Anze Zupanic
Journal:  Environ Sci Technol       Date:  2019-12-13       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.